Cogent Biosciences, Inc. (COGT) › Capital ExpendituresCogent Biosciences, Inc. (COGT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2017: $912.0K2018: $549.0K2019: $33.0K2021: $1.72M2022: $6.86M2023: $2.80M2024: $573.0K2025: $1.55M$1.55M2017Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$1.55M+171.2%2024$573.0K-79.5%2023$2.80M-59.3%2022$6.86M+299.2%2021$1.72M—2019$33.0K-94.0%2018$549.0K-39.8%2017$912.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share